211 related articles for article (PubMed ID: 31735177)
21. Diffusion-weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma.
Dubrulle F; Souillard R; Chechin D; Vaneecloo FM; Desaulty A; Vincent C
Radiology; 2006 Feb; 238(2):604-10. PubMed ID: 16304085
[TBL] [Abstract][Full Text] [Related]
22. Postoperative diffusion weighted MRI and preoperative CT scan fusion for residual cholesteatoma localization.
Alzahrani M; Alhazmi R; Bélair M; Saliba I
Int J Pediatr Otorhinolaryngol; 2016 Nov; 90():259-263. PubMed ID: 27729145
[TBL] [Abstract][Full Text] [Related]
23. Diffusion-weighted imaging for cholesteatoma evaluation.
Schwartz KM; Lane JI; Neff BA; Bolster BD; Driscoll CL; Beatty CW
Ear Nose Throat J; 2010 Apr; 89(4):E14-9. PubMed ID: 20397131
[TBL] [Abstract][Full Text] [Related]
24. Mastoid Obliteration Using S53P4 Bioactive Glass in Cholesteatoma Surgery: A 10-Year Single-Center Experience in 173 Adult Patients with Long-Term Magnetic Resonance Imaging Controlled Follow-up.
Kroon VJ; Mes SW; Borggreven PA; van de Langenberg R; Colnot DR; Quak JJ
Otol Neurotol; 2022 Dec; 43(10):1181-1188. PubMed ID: 36099589
[TBL] [Abstract][Full Text] [Related]
25. HASTE diffusion-weighted MRI for the reliable detection of cholesteatoma.
Ilıca AT; Hıdır Y; Bulakbaşı N; Satar B; Güvenç I; Arslan HH; Imre N
Diagn Interv Radiol; 2012; 18(2):153-8. PubMed ID: 21960134
[TBL] [Abstract][Full Text] [Related]
26. Endoscopic Management of Primary Acquired Cholesteatoma.
Chiao W; Chieffe D; Fina M
Otolaryngol Clin North Am; 2021 Feb; 54(1):129-145. PubMed ID: 33131767
[TBL] [Abstract][Full Text] [Related]
27. Does non-echo-planar diffusion-weighted magnetic resonance imaging have a role in assisting the clinical diagnosis of cholesteatoma in selected cases?
Nash R; Lingam RK; Chandrasekharan D; Singh A
J Laryngol Otol; 2018 Mar; 132(3):207-213. PubMed ID: 29353560
[TBL] [Abstract][Full Text] [Related]
28. Closed tympanoplasty in middle ear cholesteatoma surgery.
Lesinskas E; Vainutiene V
Medicina (Kaunas); 2004; 40(9):856-9. PubMed ID: 15456971
[TBL] [Abstract][Full Text] [Related]
29. Canal wall down mastoidectomy with obliteration versus canal wall up mastoidectomy in primary cholesteatoma surgery.
Wilkie MD; Chudek D; Webb CJ; Panarese A; Banhegyi G
J Laryngol Otol; 2019 Dec; 133(12):1074-1078. PubMed ID: 31735175
[TBL] [Abstract][Full Text] [Related]
30. The value of non echo planar, diffusion-weighted magnetic resonance imaging for the detection of residual or recurrent middle-ear cholesteatoma.
Velthuis S; van Everdingen KJ; Quak JJ; Colnot DR
J Laryngol Otol; 2014 Jul; 128(7):599-603. PubMed ID: 25003659
[TBL] [Abstract][Full Text] [Related]
31. 3T MR imaging of postoperative recurrent middle ear cholesteatomas: value of periodically rotated overlapping parallel lines with enhanced reconstruction diffusion-weighted MR imaging.
Lehmann P; Saliou G; Brochart C; Page C; Deschepper B; Vallée JN; Deramond H
AJNR Am J Neuroradiol; 2009 Feb; 30(2):423-7. PubMed ID: 18945795
[TBL] [Abstract][Full Text] [Related]
32. Utility of diffusion-weighted magnetic resonance imaging in the diagnosis of cholesteatoma and the influence of the learning curve.
Garcia-Iza L; Guisasola A; Ugarte A; Navarro JJ; Goiburu M; Altuna X
Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2227-2235. PubMed ID: 30056471
[TBL] [Abstract][Full Text] [Related]
33. Intact canal wall mastoidectomy with tympanoplasty for cholesteatoma in children.
Dodson EE; Hashisaki GT; Hobgood TC; Lambert PR
Laryngoscope; 1998 Jul; 108(7):977-83. PubMed ID: 9665242
[TBL] [Abstract][Full Text] [Related]
34. Bioactive glass granules for mastoid and epitympanic surgical obliteration: CT and MRI appearance.
Bernardeschi D; Law-Ye B; Bielle F; Hochet B; Sterkers O; Dormont D; Pyatigorskaya N
Eur Radiol; 2019 Oct; 29(10):5617-5626. PubMed ID: 30888487
[TBL] [Abstract][Full Text] [Related]
35. Middle-ear or mastoid granulation pathology associated with retraction of the pars flaccida and low-pitched tinnitus.
Lou Z
J Laryngol Otol; 2021 Apr; 135(4):332-335. PubMed ID: 33759738
[TBL] [Abstract][Full Text] [Related]
36. ADC Benchmark Range for Correct Diagnosis of Primary and Recurrent Middle Ear Cholesteatoma.
Russo C; Elefante A; Di Lullo AM; Carotenuto B; D'Amico A; Cavaliere M; Iengo M; Brunetti A
Biomed Res Int; 2018; 2018():7945482. PubMed ID: 29854790
[TBL] [Abstract][Full Text] [Related]
37. Non-EPI DW MRI in planning the surgical approach to primary and recurrent cholesteatoma.
Migirov L; Wolf M; Greenberg G; Eyal A
Otol Neurotol; 2014 Jan; 35(1):121-5. PubMed ID: 24317217
[TBL] [Abstract][Full Text] [Related]
38. The role of diffusion-weighted magnetic resonance imaging in cholesteatoma diagnosis and follow-up. Study with the diffusion PROPELLER technique.
Mateos-Fernández M; Mas-Estellés F; de Paula-Vernetta C; Guzmán-Calvete A; Villanueva-Martí R; Morera-Pérez C
Acta Otorrinolaringol Esp; 2012; 63(6):436-42. PubMed ID: 23093315
[TBL] [Abstract][Full Text] [Related]
39. Fusion of Diffusion-Weighted Magnetic Resonance Imaging and High-Resolution Computed Tomography Scan As a Preoperative Tool for Classification of Middle Ear Cholesteatoma.
Galal A; ElNaggar M; Omran A; Eid M; Badr-El-Dine M
J Int Adv Otol; 2022 Nov; 18(6):507-512. PubMed ID: 36349673
[TBL] [Abstract][Full Text] [Related]
40. Surgical strategy for cholesteatoma in children.
Ueda H; Nakashima T; Nakata S
Auris Nasus Larynx; 2001 Apr; 28(2):125-9. PubMed ID: 11240319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
